On This Page

Filter

These are the filters currently being used to limit the search results. Click on the
icon to remove the filter.

tabling member › label

Biography information for Mary Glindon

Sort by

This list shows the properties that you can sort by. Click on to sort in ascending order and to sort in descending order. The properties that you're currently sorting by are
shown at the top of the list. Click on to remove a sort and or to reverse the current sort order. Click on the icon to remove all the sorting. Note that sorting can significantly slow down the
loading of the page.

View

Choose what information you want to view about each item. There are some pre-defined
views, but starred properties are always present no matter what the view. You can
star properties by clicking on the icon. The currently starred icons have a icon; clicking on it will unstar the property.

<p>​The UK retains strong relations with the Kurdistan Region of Iraq (KRI). British
Ministers and officials regularly engage with KRI representatives. On 1 September
our Ambassador to Iraq met the KRI Prime Minister, Masrour Barzani, to discuss latest
developments and I spoke to the KRI President, Nechirvan Barzani, on 12 June. The
UK also provides significant support to the KRI, including through training assistance
to the Peshmerga, humanitarian aid, advice on economic reform, and continued efforts
to deepen UK-KRI trade.</p>

To ask the Secretary of State for Health and Social Care, what alternative arrangements
will be introduced in the new local pharmacy contract to safeguard people taking multiple
medications and ensure they receive a regular review of their medication to prevent
contraindications.

<p>Medicines Usage Reviews (MURs) are adherence centred reviews with the community
pharmacist in isolation from the prescriber. The new Structured Medication Reviews,
offered by clinical pharmacists working in primary care networks (PCNs), will provide
a more comprehensive review of a patient’s medication with access to the patient record
and with the greater ability of clinical pharmacists to make independent decisions
to change medication, if that is the result of a review. It is expected that community
pharmacists and practice-based pharmacists will work closely together to optimise
medicines usage.</p><p>Recently announced changes to the Community Pharmacy Contractual
Framework, include a Medicines Reconciliation Service, through which community pharmacists
will be expected to collaborate with PCN pharmacists and prescribers, to ensure patients
are clear about changes to their medicines, post-discharge, in line with the National
Institute for Health and Care Excellence guideline on medicines optimisation. The
Pharmacy Quality Scheme and the general practice Quality and Outcomes Framework Quality
Improvement modules incentivise PCNs and community pharmacy to identify those taking
high risk medicines and take actions to reduce risks where appropriate.</p>

<p>I refer the hon. Member to the answers the then Minister of State for Health (Stephen
Hammond MP) gave on 4 July 2019 to Questions <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-07-01/271535/"
target="_blank">271535</a> and <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-07-01/271536/"
target="_blank">271536</a>.</p>

To ask the Secretary of State for Health and Social Care, what steps the NHS will
take as part of the forthcoming NHS workforce plan to minimise the vacancy rates of
(a) Parkinson’s nurses and (b) other specialist posts.

<p>I refer the hon. Member to the answers the then Minister of State for Health (Stephen
Hammond MP) gave on 4 July 2019 to Questions <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-07-01/271535/"
target="_blank">271535</a> and <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-07-01/271536/"
target="_blank">271536</a>.</p>

<p>This data has been extracted from the relevant editions of the National Statistics:
‘General Pharmaceutical Services’ for England, which is published on an annual basis
by NHS Digital and compares a rolling 10 years data:</p><p> </p><p>2005/06: 148,195</p><p>2006/07:
559,315</p><p>2007/08: 951,358</p><p>2008/09: 1,397,319</p><p>2009/10: 1,707,139</p><p>2010/11:
2,108,604</p><p>2011/12: 2,434,128</p><p>2012/13: 2,820,415</p><p>2013/14: 3,081,108</p><p>2014/15:
3,183,094</p><p>2015/16: 3,313,309</p><p>2016/17: 3,368,005</p><p>2017/18: 3,381,441</p><p>2018/19:
Not yet published</p>

<p>Since 2014, community pharmacy contractors have been required to conduct 70% of
the Medicines Use Reviews (MURs) that they undertake on the following target groups
and data is collected accordingly:</p><p>- Patients taking high-risk medicines (Non-steroidal
anti-inflammatory drugs, anticoagulants, antiplatelets and diuretics);</p><p>- Patients
recently discharged from hospital;</p><p>- Patients prescribed a respiratory drug,
as specified; and</p><p>- Patients regularly prescribed four or more medicines, at
least one of which is for a risk of cardiovascular disease, as specified.</p><p>Specific
data is not collected on the remaining 30% and so it is not possible to say how many
people taking medicines for Parkinson’s disease have received an MUR.</p>

<p>In line with other measures around releasing sensitive data in internal Impact
Assessments, the final Impact Assessment produced in July 2019 in respect of the new
Community Pharmacy Contractual Framework, which did include material relating to ending
Medicines Usage Reviews, is not being published at this time.</p>

<p>There has never been any question that this Government’s policies on animal welfare
are driven by the fact that animals are sentient beings. However, the Government has
been very clear that we will make any necessary changes required to UK law in a rigorous
and comprehensive way to ensure animal sentience is recognised after we leave the
EU.</p>